Clinical Trial Update: AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating AZD9150 alone or with durvalumab, with or without chemotherapy, in patients with advanced solid tumors and non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• AZD9150
• Durvalumab (durvalumab)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Solid Tumours | Phase 1 | Status: COMPLETED